Revision in Outcome of Board Meeting - Shifting of Registered Office
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
At its meeting on March 10, 2026, the board of Covidh Technologies approved several major changes. The company proposes to rename itself from "Covidh Technologies Limited" to "iSERA Lifesciences Limited," pending shareholder approval, signaling a strategic shift toward the pharmaceutical and biotechnology space. The registered office will shift within Pune from Shukrawar Peth to Boulevard Tower in Camp, effective April 1, 2026. The board also recommended appointing four new directors — two Executive Directors (Mr. Dhairyasheel Yadav with 18+ years and Mr. Nandkumar Kadam with 20+ years in pharma/biotech) and two Non-Executive Directors — all for a five-year term. An Extraordinary General Meeting (EGM) is scheduled for April 2, 2026 via video conferencing to seek shareholder approval for these proposals.
This looks like a significant strategic pivot from a technology identity to a life sciences identity, backed by a board with deep pharma and biotech expertise. Shareholders will vote on these changes at the April 2, 2026 EGM, and the outcome could reshape the company's market positioning and investor perception.